Literature DB >> 18566590

The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.

Min Sup Song1, Su Jung Song, So Yeon Kim, Hyun Jung Oh, Dae-Sik Lim.   

Abstract

The tumour suppressor p53, which accumulates in response to DNA damage and induces cell-cycle arrest and apoptosis, has a key function in the maintenance of genome integrity. Under normal conditions, the antiproliferative effects of p53 are inhibited by MDM2, a ubiquitin ligase that promotes p53 ubiquitination and degradation. MDM2 is also self-ubiquitinated and degraded. Here, we show that the tumour suppressor RASSF1A regulates G(1)-S cell-cycle progression in a p53-dependent manner by promoting MDM2 self-ubiquitination and preventing p53 degradation. Importantly, RASSF1A associates with MDM2 and death-domain-associated protein (DAXX) in the nucleus, thereby disrupting the interactions between MDM2, DAXX, and the deubiquitinase, HAUSP, and enhancing the self-ubiquitin ligase activity of MDM2. Moreover, RASSF1A partially contributes to p53-dependent checkpoint activation at early time points in response to DNA damage. These findings reveal a new and important function for RASSF1A in regulating the p53-MDM2 pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566590      PMCID: PMC2486425          DOI: 10.1038/emboj.2008.115

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation.

Authors:  Laurent Le Cam; Laëtitia K Linares; Conception Paul; Eric Julien; Matthieu Lacroix; Elodie Hatchi; Robinson Triboulet; Guillaume Bossis; Ayelet Shmueli; Manuel S Rodriguez; Olivier Coux; Claude Sardet
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

2.  Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation.

Authors:  Daiju Kitagawa; Hiroaki Kajiho; Takahiro Negishi; Seiji Ura; Tomomi Watanabe; Teiji Wada; Hidenori Ichijo; Toshiaki Katada; Hiroshi Nishina
Journal:  EMBO J       Date:  2006-06-29       Impact factor: 11.598

3.  RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network.

Authors:  Cai Guo; Stella Tommasi; Limin Liu; Jiing-Kuan Yee; Reinhard Dammann; Gerd P Pfeifer
Journal:  Curr Biol       Date:  2007-03-22       Impact factor: 10.834

4.  Inactivation of the p53 pathway in retinoblastoma.

Authors:  Nikia A Laurie; Stacy L Donovan; Chie-Schin Shih; Jiakun Zhang; Nicholas Mills; Christine Fuller; Amina Teunisse; Suzanne Lam; Yolande Ramos; Adithi Mohan; Dianna Johnson; Matthew Wilson; Carlos Rodriguez-Galindo; Micaela Quarto; Sarah Francoz; Susan M Mendrysa; R Kiplin Guy; Jean-Christophe Marine; Aart G Jochemsen; Michael A Dyer
Journal:  Nature       Date:  2006-11-02       Impact factor: 49.962

Review 5.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

Review 6.  The RASSF1A tumor suppressor.

Authors:  Howard Donninger; Michele D Vos; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2007-09-15       Impact factor: 5.285

7.  Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1-S transition.

Authors:  M S Song; S J Song; S J Kim; K Nakayama; K I Nakayama; D-S Lim
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

8.  A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability.

Authors:  Michele D Vos; Alfredo Martinez; Candice Elam; Ashraf Dallol; Barbara J Taylor; Farida Latif; Geoffrey J Clark
Journal:  Cancer Res       Date:  2004-06-15       Impact factor: 12.701

9.  Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis.

Authors:  Hyun Jung Oh; Kyung-Kwon Lee; Su Jung Song; Mi Sun Jin; Min Sup Song; Joo Hyun Lee; Chang Rak Im; Jie-Oh Lee; Shin Yonehara; Dae-Sik Lim
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

10.  RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein.

Authors:  David Matallanas; David Romano; Karen Yee; Katrin Meissl; Lucia Kucerova; Daniela Piazzolla; Manuela Baccarini; J Keith Vass; Walter Kolch; Eric O'neill
Journal:  Mol Cell       Date:  2007-09-21       Impact factor: 17.970

View more
  59 in total

Review 1.  Tied up in loops: positive and negative autoregulation of p53.

Authors:  Xin Lu
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

2.  Overexpression of SUMO-1 in hepatocellular carcinoma: a latent target for diagnosis and therapy of hepatoma.

Authors:  Wu-Hua Guo; Li-Hua Yuan; Zhi-Hua Xiao; Dan Liu; Ji-Xiang Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-26       Impact factor: 4.553

3.  Loss of DDRGK1 modulates SOX9 ubiquitination in spondyloepimetaphyseal dysplasia.

Authors:  Adetutu T Egunsola; Yangjin Bae; Ming-Ming Jiang; David S Liu; Yuqing Chen-Evenson; Terry Bertin; Shan Chen; James T Lu; Lisette Nevarez; Nurit Magal; Annick Raas-Rothschild; Eric C Swindell; Daniel H Cohn; Richard A Gibbs; Philippe M Campeau; Mordechai Shohat; Brendan H Lee
Journal:  J Clin Invest       Date:  2017-03-06       Impact factor: 14.808

Review 4.  The role of deubiquitinating enzymes in chromatin regulation.

Authors:  Boyko S Atanassov; Evangelia Koutelou; Sharon Y Dent
Journal:  FEBS Lett       Date:  2010-10-26       Impact factor: 4.124

Review 5.  Multitasking with ubiquitin through multivalent interactions.

Authors:  Fen Liu; Kylie J Walters
Journal:  Trends Biochem Sci       Date:  2010-02-22       Impact factor: 13.807

6.  A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.

Authors:  Karen S Yee; Lukasz Grochola; Garth Hamilton; Anna Grawenda; Elisabeth E Bond; Helge Taubert; Peter Wurl; Gareth L Bond; Eric O'Neill
Journal:  Cancer Res       Date:  2012-03-02       Impact factor: 12.701

7.  Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine.

Authors:  Pinelopi Nterma; Eleni Panopoulou; Eleni Papadaki-Petrou; Martha Assimakopoulou
Journal:  Pathol Oncol Res       Date:  2019-01-02       Impact factor: 3.201

8.  Methylation of RASSF1A gene promoter is regulated by p53 and DAXX.

Authors:  Hailong Zhang; Jing He; Jiansha Li; Dan Tian; Lubing Gu; Muxiang Zhou
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

9.  ATM regulates a RASSF1A-dependent DNA damage response.

Authors:  Garth Hamilton; Karen S Yee; Simon Scrace; Eric O'Neill
Journal:  Curr Biol       Date:  2009-12-03       Impact factor: 10.834

10.  The Many Faces of MDM2 Binding Partners.

Authors:  Maurisa F Riley; Guillermina Lozano
Journal:  Genes Cancer       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.